Biopharma company Pelthos Therapeutics has acquired the US commercialization rights to Xepi (ozenoxacin) Cream, 1%, from ...

The US Food and Drug Administration (FDA) has approved Johnson & Johnson’s Darzalex Faspro (daratumumab and ...

Danish biotech Genmab reported a 25% rise in its total revenue to $1.02 billion during the third quarter of 2025, ahead of ...

German pharma major Bayer announced new Phase III investigational data from the pivotal FINE-ONE trial showing that Kerendia ...

Healthcare giant Johnson & Johnson has announced that the US Food and Drug Administration (FDA) has approved Caplyta ...

Danish diabetes and obesity drug giant Novo Nordisk has agreed with the US Administration to lower drug prices beginning in ...

Danish pharma major Novo Nordisk (NOV: N) has presented new post-hoc analyses from the Phase III REDEFINE 1 trial evaluating ...

The global endometrial cancer market is on course for steady expansion, projected to reach nearly $39 billion by 2030. Growth ...

Eli Lilly (NYSE: LLY) is preparing to start Phase III trials of its experimental obesity therapy eloralintide by year-end, ...

The USA’s Centers for Medicare & Medicaid Services (CMS) is tackling high drug prices and protecting the American taxpayers ...

The Russian government has proposed a new mechanism for subsidization of works for development of new drugs, reports The ...

Belgian biopharma company UCB (Euronext: UCB) has announced a leadership reshuffle, effective January 1, 2026, as part of a ...